Today: 19 May 2026
BAT share price today: British American Tobacco stock rises after fresh buyback disclosure
17 February 2026
1 min read

BAT share price today: British American Tobacco stock rises after fresh buyback disclosure

LONDON, Feb 17, 2026, 08:29 GMT — Regular session running.

  • British American Tobacco picked up 0.8% to trade at 4,340 pence right after the open.
  • The company said it picked up 112,212 shares in its buyback program on Feb. 16.
  • Traders are watching for a U.S. vape decision expected in March, with BAT’s ex-dividend date falling on March 26.

Shares of British American Tobacco edged 0.8% higher to 4,340 pence by 0829 GMT on Tuesday in London, following news of fresh buys under its ongoing share repurchase scheme. The company reported another round of purchases.

BAT’s reliance on cash returns has helped steady investors as it pours money into “smokeless” categories—think nicotine pouches and vapes. Buybacks—essentially the company scooping up its own shares—have a way of boosting earnings per share by cutting down the number of shares out there.

BAT disclosed in a separate Monday filing that Chief Executive Tadeu Marroco, along with a person closely linked to him, picked up 157 shares each by reinvesting dividend payouts—a modest move, but one that tends to draw attention from those tracking insider activity.

BAT ended Monday’s session at 4,305 pence, exchange data from Yahoo Finance shows.

Last week, the company posted its full-year numbers. Annual profit climbed, helped by Velo nicotine pouches picking up more U.S. market share. Management also pointed to an AI-driven productivity plan that may result in job losses, though Interim CFO Javed Iqbal said it’s still too soon to estimate the scale.

Regulation headaches persist. BAT told Reuters a possible U.S. import ban targeting unauthorized disposable vapes could slash America’s illicit vape market by as much as a third. The U.S. International Trade Commission will make its call in March 2026, and then there’s a 60-day window for presidential review.

It’s a close contest. Philip Morris’s Zyn remains the frontrunner in U.S. nicotine pouches, but Jefferies analyst Andrei Andon-Ionita thinks BAT has a real shot at grabbing more share in the space.

Familiar risks still hang over the sector: illegal products grabbing share, the threat of stricter regulations arriving sooner than the market expects, and pricing pressure squeezing margins. BAT, in its results statement, flagged continued fallout from “illicit proliferation” in the vapour segment. The company also highlighted regulatory and tax headwinds in Bangladesh and Australia. https://www.bat.com/media/press-releases/_…

Investors now turn to the March ITC decision stateside, as well as BAT’s upcoming dividend schedule. Shares go ex-dividend March 26, with payment following on May 7 under the LSE calendar.

Stock Market Today

  • Q1 Earnings Review: Netflix, Roku, Coursera Show Mixed Consumer Subscription Stock Results
    May 19, 2026, 9:48 AM EDT. Consumer subscription stocks posted mixed Q1 results with revenues surpassing estimates by 1.6% collectively. Netflix's (NASDAQ:NFLX) revenue rose 16.2% to $12.25 billion, beating expectations by 0.5%, but shares fell 16.8% on lowered earnings guidance. Roku (NASDAQ:ROKU) led with 22.4% revenue growth and strong EBITDA outlook, lifting shares 6.7%. Coursera (NYSE:COUR) reported 9.1% revenue growth in line with forecasts but guidance missed slightly, resulting in a 4.6% share decline. The sector is down 7.7% on average post-earnings, reflecting investor caution amid uneven results.

Latest articles

Relay Therapeutics Stock Jumps Before The Bell — The Drug Data Investors Are Watching

Relay Therapeutics Stock Jumps Before The Bell — The Drug Data Investors Are Watching

19 May 2026
Relay Therapeutics shares jumped 11.3% to $13.47 in premarket trading Tuesday after reporting a 60% volumetric response rate in 20 evaluable patients from its Phase 2 trial of zovegalisib for vascular anomalies. The company said 95% of patients saw some lesion reduction at 12 weeks. No patients discontinued due to adverse events. The regular Nasdaq session was set to open at 9:30 a.m. ET.
Rubico Shares Surge Before Market Open on Volume Spike

Rubico Shares Surge Before Market Open on Volume Spike

19 May 2026
Rubico Inc shares jumped 127.75% to $3.94 in U.S. premarket trading Tuesday, with volume surging to 34.04 million shares versus an average of 95,000. The move followed a May 8 SEC filing for a proposed unit offering with warrants, which could price below market. No new earnings report was released. Rubico operates two Suezmax crude-oil tankers and recently completed a one-for-10 reverse stock split.

Popular

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

19 May 2026
Sunshine Biopharma shares surged as much as 516% before settling up 78% at $0.51 in heavy after-hours Nasdaq trading Monday, following a $6 million public offering priced at $0.50 per unit. More than 436 million shares changed hands, far exceeding the company’s 5 million shares outstanding. The deal includes 12 million units with warrants, raising dilution concerns. Closing is expected around May 19.
Strike threat at Futamura: Wigton packaging workers reject 1.2% pay rise, set vote
Previous Story

Strike threat at Futamura: Wigton packaging workers reject 1.2% pay rise, set vote

British American Tobacco share price rises early as BAT reiterates 2026 outlook and keeps buyback running
Next Story

British American Tobacco share price rises early as BAT reiterates 2026 outlook and keeps buyback running

Go toTop